FdaApplication
ANDA 212701
Identifiers
- fda_app_no: ANDA212701
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-05-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPSONE | DAPSONE | 7.5% | GEL;TOPICAL |
1 product